FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294754752> ?p ?o ?g. }

• W4294754752 endingPage "3310" @default.
• W4294754752 startingPage "3299" @default.
• W4294754752 abstract "Aim: To examine characteristics of and treatment duration and real-world overall survival (rwOS) in patients receiving cetuximab as second-line (2L) or third-line (3L) treatment for metastatic colorectal cancer. Materials & methods: This was a retrospective study of 1096 and 684 patients in 2L and 3L cohorts, respectively. Results: The most common cetuximab-based regimens were cetuximab + folinic acid, fluorouracil and irinotecan (2L: 44%; 3L: 32%) and cetuximab + irinotecan (2L: 28%; 3L: 35%). Kaplan-Meier survival estimates and stepwise Cox regression model analysis demonstrated median treatment duration and rwOS of 3.7 and 14.4 months, respectively, in patients receiving treatment in the 2L cohort. In the 3L cohort, treatment duration was 3.3 months and rwOS was 12.0 months. Conclusion: This large real-world study provides evidence of rwOS in patients with metastatic colorectal cancer receiving cetuximab-based regimens as 2L or 3L treatment.In this retrospective study, the authors examined baseline characteristics of and treatment duration and real-world overall survival (rwOS) in 1096 and 684 patients with metastatic colorectal cancer receiving cetuximab as second-line (2L) and third-line (3L) treatment, respectively. The most common cetuximab-based regimens were cetuximab + folinic acid, fluorouracil and irinotecan (2L: 44%; 3L: 32%) and cetuximab + irinotecan (2L: 28%; 3L: 35%). Median treatment duration and rwOS were 3.7 and 14.4 months, respectively, in patients receiving treatment in the 2L cohort. In the 3L cohort, median treatment duration was 3.3 months and rwOS was 12.0 months. This large real-world study provides evidence of rwOS in patients with metastatic colorectal cancer receiving cetuximab-based regimens as 2L or 3L treatment." @default.
• W4294754752 created "2022-09-06" @default.
• W4294754752 creator A5032352726 @default.
• W4294754752 creator A5052523617 @default.
• W4294754752 creator A5063053695 @default.
• W4294754752 creator A5086276199 @default.
• W4294754752 creator A5091535739 @default.
• W4294754752 date "2022-09-01" @default.
• W4294754752 modified "2023-09-23" @default.
• W4294754752 title "Real-world overall survival of patients receiving cetuximab in later lines of treatment for metastatic colorectal cancer" @default.
• W4294754752 cites W2137759849 @default.
• W4294754752 cites W2142564546 @default.
• W4294754752 cites W2148727529 @default.
• W4294754752 cites W2156700619 @default.
• W4294754752 cites W2311784214 @default.
• W4294754752 cites W2712978371 @default.
• W4294754752 cites W2790477022 @default.
• W4294754752 cites W2794377511 @default.
• W4294754752 cites W2798183864 @default.
• W4294754752 cites W2892347132 @default.
• W4294754752 cites W2896312337 @default.
• W4294754752 cites W2903840139 @default.
• W4294754752 cites W2909492835 @default.
• W4294754752 cites W3009766810 @default.
• W4294754752 cites W3011920798 @default.
• W4294754752 cites W3013165212 @default.
• W4294754752 cites W3101925122 @default.
• W4294754752 cites W3130224122 @default.
• W4294754752 cites W3134887329 @default.
• W4294754752 cites W3153739010 @default.
• W4294754752 cites W3158213000 @default.
• W4294754752 cites W3162883085 @default.
• W4294754752 cites W3167465369 @default.
• W4294754752 doi "https://doi.org/10.2217/fon-2022-0432" @default.
• W4294754752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36066242" @default.
• W4294754752 hasPublicationYear "2022" @default.
• W4294754752 type Work @default.
• W4294754752 citedByCount "0" @default.
• W4294754752 crossrefType "journal-article" @default.
• W4294754752 hasAuthorship W4294754752A5032352726 @default.
• W4294754752 hasAuthorship W4294754752A5052523617 @default.
• W4294754752 hasAuthorship W4294754752A5063053695 @default.
• W4294754752 hasAuthorship W4294754752A5086276199 @default.
• W4294754752 hasAuthorship W4294754752A5091535739 @default.
• W4294754752 hasConcept C121608353 @default.
• W4294754752 hasConcept C126322002 @default.
• W4294754752 hasConcept C143998085 @default.
• W4294754752 hasConcept C167135981 @default.
• W4294754752 hasConcept C207103383 @default.
• W4294754752 hasConcept C2779804826 @default.
• W4294754752 hasConcept C2779998722 @default.
• W4294754752 hasConcept C2780259306 @default.
• W4294754752 hasConcept C44249647 @default.
• W4294754752 hasConcept C50382708 @default.
• W4294754752 hasConcept C526805850 @default.
• W4294754752 hasConcept C71924100 @default.
• W4294754752 hasConcept C72563966 @default.
• W4294754752 hasConceptScore W4294754752C121608353 @default.
• W4294754752 hasConceptScore W4294754752C126322002 @default.
• W4294754752 hasConceptScore W4294754752C143998085 @default.
• W4294754752 hasConceptScore W4294754752C167135981 @default.
• W4294754752 hasConceptScore W4294754752C207103383 @default.
• W4294754752 hasConceptScore W4294754752C2779804826 @default.
• W4294754752 hasConceptScore W4294754752C2779998722 @default.
• W4294754752 hasConceptScore W4294754752C2780259306 @default.
• W4294754752 hasConceptScore W4294754752C44249647 @default.
• W4294754752 hasConceptScore W4294754752C50382708 @default.
• W4294754752 hasConceptScore W4294754752C526805850 @default.
• W4294754752 hasConceptScore W4294754752C71924100 @default.
• W4294754752 hasConceptScore W4294754752C72563966 @default.
• W4294754752 hasFunder F4320307758 @default.
• W4294754752 hasIssue "29" @default.
• W4294754752 hasLocation W42947547521 @default.
• W4294754752 hasLocation W42947547522 @default.
• W4294754752 hasOpenAccess W4294754752 @default.
• W4294754752 hasPrimaryLocation W42947547521 @default.
• W4294754752 hasRelatedWork W2009962406 @default.
• W4294754752 hasRelatedWork W2010928484 @default.
• W4294754752 hasRelatedWork W2080692829 @default.
• W4294754752 hasRelatedWork W2280217121 @default.
• W4294754752 hasRelatedWork W2435704186 @default.
• W4294754752 hasRelatedWork W2588930642 @default.
• W4294754752 hasRelatedWork W2890323486 @default.
• W4294754752 hasRelatedWork W2898494785 @default.
• W4294754752 hasRelatedWork W2984714837 @default.
• W4294754752 hasRelatedWork W3036837279 @default.
• W4294754752 hasVolume "18" @default.
• W4294754752 isParatext "false" @default.
• W4294754752 isRetracted "false" @default.
• W4294754752 workType "article" @default.